{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:11:25Z","timestamp":1792714285814,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.critrevonc.2026.105181","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T16:33:58Z","timestamp":1770222838000},"page":"105181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Optimizing bridging radiotherapy prior to CAR-T cell therapy: An evidence-based approach"],"prefix":"10.1016","volume":"220","author":[{"given":"Pierre","family":"Loap","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9mentine","family":"Sarkozy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remi","family":"Dendale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youlia","family":"Kirova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2026.105181_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109933","article-title":"Radiation therapy as a bridging and salvage strategy in patients with relapsed or refractory multiple myeloma undergoing BCMA-targeted CAR T-cell therapy","volume":"189","author":"Ababneh","year":"2023","journal-title":"Radio. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105181_bib2","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(24)01774-4","article-title":"Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial","volume":"404","author":"Abramson","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2026.105181_bib3","article-title":"ESMO-ESTRO framework for assessing the interactions and safety of combining radiotherapy with targeted cancer therapies or immunotherapy","volume":"208","author":"Aken","year":"2025","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105181_bib4","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/(SICI)1520-6823(1999)7:3<158::AID-ROI4>3.0.CO;2-B","article-title":"Radiobiological characterization of two human chemotherapy-resistant intermediate grade non-Hodgkin\u2019s lymphoma cell lines","volume":"7","author":"Aref","year":"1999","journal-title":"Radiat. Oncol. Invest."},{"key":"10.1016\/j.critrevonc.2026.105181_bib5","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3109\/10428199909058479","article-title":"Therapeutic and prognostic implications of peripheral blood lymphopenia in patients with Hodgkin\u2019s disease","volume":"34","author":"Ayoub","year":"1999","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.critrevonc.2026.105181_bib6","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20210618","article-title":"The role of motion management and position verification in lymphoma radiotherapy","volume":"94","author":"Aznar","year":"2021","journal-title":"Br. J. Radio."},{"key":"10.1016\/j.critrevonc.2026.105181_bib7","first-page":"606","article-title":"18F-FDG PET early after radiotherapy in lymphoma patients","volume":"19","author":"Castellucci","year":"2004","journal-title":"Cancer Biother. Radio."},{"key":"10.1016\/j.critrevonc.2026.105181_bib8","doi-asserted-by":"crossref","first-page":"5192","DOI":"10.1182\/bloodadvances.2024013393","article-title":"CNS bridging radiotherapy achieves rapid cytoreduction before CAR T-cell therapy for aggressive B-cell lymphomas","volume":"8","author":"Cederquist","year":"2024","journal-title":"Blood Adv."},{"key":"10.1016\/j.critrevonc.2026.105181_bib9","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.ijrobp.2010.01.051","article-title":"Feasibility of helical tomotherapy for debulking irradiation before stem cell transplantation in malignant lymphoma","volume":"81","author":"Chargari","year":"2011","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2026.105181_bib10","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1080\/21645515.2020.1840254","article-title":"Effect of radiotherapy on T cell and PD-1 \/ PD-L1 blocking therapy in tumor microenvironment","volume":"17","author":"Chen","year":"2021","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.critrevonc.2026.105181_bib11","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/s41375-024-02213-x","article-title":"Axicabtagene ciloleucel treatment is more effective in primary mediastinal large B-cell lymphomas than in diffuse large B-cell lymphomas: the Italian CART-SIE study","volume":"38","author":"Chiappella","year":"2024","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2026.105181_bib12","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1080\/0284186X.2022.2073186","article-title":"Radiotherapy respiratory motion management in hepatobiliary and pancreatic malignancies: a systematic review of patient factors influencing effectiveness of motion reduction with abdominal compression","volume":"61","author":"Daly","year":"2022","journal-title":"Acta Oncol."},{"key":"10.1016\/j.critrevonc.2026.105181_bib13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1748-717X-5-55","article-title":"Definitive radiotherapy and single-agent radiosensitizing ifosfamide in patients with localized, irresectable soft tissue sarcoma: a retrospective analysis","volume":"5","author":"Eckert","year":"2010","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105181_bib14","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008973","article-title":"Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in mice","volume":"6","author":"Favaudon","year":"2014","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.critrevonc.2026.105181_bib15","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/s41591-021-01622-0","article-title":"Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial","volume":"28","author":"Fowler","year":"2022","journal-title":"Nat. Med"},{"key":"10.1016\/j.critrevonc.2026.105181_bib16","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/jamaoncol.2021.0168","article-title":"Radiotherapy to Enhance Chimeric Antigen Receptor T-Cell Therapeutic Efficacy in Solid Tumors: A Narrative Review","volume":"7","author":"Hauth","year":"2021","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.critrevonc.2026.105181_bib17","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12885-024-11837-2","article-title":"Hypofractionated radiotherapy for refractory or relapsed aggressive B-cell lymphoma in the rituximab era","volume":"24","author":"Huang","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2026.105181_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/hem3.62","article-title":"Treatment outcomes in patients with large B-cell lymphoma after progression to chimeric antigen receptor T-cell therapy","volume":"8","author":"Iacoboni","year":"2024","journal-title":"Hemasphere"},{"key":"10.1016\/j.critrevonc.2026.105181_bib19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1470-2045(21)00591-X","article-title":"Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial","volume":"23","author":"Jacobson","year":"2022","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2026.105181_bib20","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.ijrobp.2024.01.224","article-title":"FLASH Proton Radiation Therapy Mitigates Inflammatory and Fibrotic Pathways and Preserves Cardiac Function in a Preclinical Mouse Model of Radiation-Induced Heart Disease","volume":"119","author":"Kim","year":"2024","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2026.105181_bib21","first-page":"e471","article-title":"Impact of Salvage Versus Palliative Dose Bridging Radiation Therapy on Local Control and Overall Survival in Patients with DLBCL Receiving CD19 CAR T Cell Therapy","volume":"117","author":"Kiser","year":"2023","journal-title":"Int. J. Radiat. Oncol. *Biol. *Phys. ASTRO 2023 65th Annu. Meet."},{"key":"10.1016\/j.critrevonc.2026.105181_bib22","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1007\/s00330-019-06134-7","article-title":"Early evaluation of tumor response to 90Y-ibritumomab radioimmunotherapy in relapsed\/refractory B cell non-Hodgkin lymphoma: what is the optimal timing for FDG-PET\/CT?","volume":"29","author":"Kitajima","year":"2019","journal-title":"Eur. Radio."},{"key":"10.1016\/j.critrevonc.2026.105181_bib23","doi-asserted-by":"crossref","first-page":"6308","DOI":"10.1182\/bloodadvances.2024012599","article-title":"Local radiation enhances systemic CAR T-cell efficacy by augmenting antigen crosspresentation and T-cell infiltration","volume":"8","author":"Kostopoulos","year":"2024","journal-title":"Blood Adv."},{"key":"10.1016\/j.critrevonc.2026.105181_bib24","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/bjh.19453","article-title":"Outcome and feasibility of radiotherapy bridging in large B-cell lymphoma patients receiving CD19 CAR T in the UK","volume":"205","author":"Kuhnl","year":"2024","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.critrevonc.2026.105181_bib25","article-title":"Adjuvant Scrotal Radiation Therapy As Bridging Therapy to Chimeric Antigen Receptor T-Cell Following Extramedullary Relapse in B-Cell Acute Lymphoblastic Leukemia","volume":"13","author":"Ladbury","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.critrevonc.2026.105181_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.111258","article-title":"Bridging radiotherapy for chimeric antigen receptor T cells therapy in non-Hodgkin lymphoma: Systematic review and meta-analysis","volume":"214","author":"Lam","year":"2026","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105181_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-78017-7","article-title":"Abdominal FLASH irradiation reduces radiation-induced gastrointestinal toxicity for the treatment of ovarian cancer in mice","volume":"10","author":"Levy","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2026.105181_bib28","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41419-023-06211-2","article-title":"Radiotherapy remodels the tumor microenvironment for enhancing immunotherapeutic sensitivity","volume":"14","author":"Liu","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.critrevonc.2026.105181_bib29","doi-asserted-by":"crossref","first-page":"118.e1","DOI":"10.1016\/j.jtct.2021.11.016","article-title":"Absolute Lymphocyte Count Prior to Lymphodepletion Impacts Outcomes in Multiple Myeloma Patients Treated with Chimeric Antigen Receptor T Cells","volume":"28","author":"Liu","year":"2022","journal-title":"Transplant. Cell. Ther."},{"key":"10.1016\/j.critrevonc.2026.105181_bib30","article-title":"Proton Therapy Reduces the Effective Dose to Immune Cells in Mediastinal Hodgkin Lymphoma Patients","volume":"13","author":"Loap","year":"2024","journal-title":"Int J. Part Ther."},{"key":"10.1016\/j.critrevonc.2026.105181_bib31","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.3390\/cancers13153744","article-title":"Development and Implementation of Proton Therapy for Hodgkin Lymphoma: Challenges and Perspectives","volume":"13","author":"Loap","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.critrevonc.2026.105181_bib32","article-title":"Exposure to the immune system during bridging radiotherapy for Car-T cells","volume":"29","author":"Loap","year":"2025","journal-title":"Cancer Radio."},{"issue":"21","key":"10.1016\/j.critrevonc.2026.105181_bib33","article-title":"Clinical and technical considerations for mediastinal Hodgkin lymphoma protontherapy based on a single-center early experience","volume":"S1278-3218","author":"Loap","year":"2021","journal-title":"Cancer Radio."},{"key":"10.1016\/j.critrevonc.2026.105181_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.prro.2022.02.004","article-title":"Development of simplified auto-segmentable functional cardiac atlas","author":"Loap","year":"2022","journal-title":"Pract. Radiat. Oncol. 0"},{"key":"10.1016\/j.critrevonc.2026.105181_bib35","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/0284186X.2021.2025265","article-title":"Cardiac conduction system exposure with modern radiotherapy techniques for mediastinal Hodgkin lymphoma irradiation","volume":"61","author":"Loap","year":"2022","journal-title":"Acta Oncol."},{"key":"10.1016\/j.critrevonc.2026.105181_bib36","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1080\/0284186X.2022.2084639","article-title":"Cardiotoxicity model-based patient selection for Hodgkin lymphoma proton therapy","volume":"61","author":"Loap","year":"2022","journal-title":"Acta Oncol."},{"key":"10.1016\/j.critrevonc.2026.105181_bib37","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.canrad.2020.04.012","article-title":"Evaluation of a delineation software for cardiac atlas-based autosegmentation: An example of the use of artificial intelligence in modern radiotherapy","volume":"24","author":"Loap","year":"2020","journal-title":"Cancer Radio."},{"key":"10.1016\/j.critrevonc.2026.105181_bib38","doi-asserted-by":"crossref","first-page":"6580","DOI":"10.1158\/1078-0432.CCR-21-0308","article-title":"The Safety of Bridging Radiation with Anti-BCMA CAR T-Cell Therapy for Multiple Myeloma","volume":"27","author":"Manjunath","year":"2021","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.critrevonc.2026.105181_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28870","article-title":"Use of cardiac radiation therapy as bridging therapy to CAR-T for relapsed pediatric B-cell acute lymphoblastic leukemia","volume":"68","author":"Marquez","year":"2021","journal-title":"Pedia Blood Cancer"},{"key":"10.1016\/j.critrevonc.2026.105181_bib40","doi-asserted-by":"crossref","first-page":"PL237","DOI":"10.1016\/0024-3205(93)90544-D","article-title":"The interaction of etoposide with radiation: Variation in cytotoxicity with the sequence of treatment","volume":"53","author":"Minehan","year":"1993","journal-title":"Life Sci."},{"key":"10.1016\/j.critrevonc.2026.105181_bib41","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1007\/s00259-020-05125-x","article-title":"Deep learning-based auto-delineation of gross tumour volumes and involved nodes in PET\/CT images of head and neck cancer patients","volume":"48","author":"Moe","year":"2021","journal-title":"Eur. J. Nucl. Med Mol. Imaging"},{"key":"10.1016\/j.critrevonc.2026.105181_bib42","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.radonc.2017.05.003","article-title":"Irradiation in a flash: Unique sparing of memory in mice after whole brain irradiation with dose rates above 100Gy\/s","volume":"124","author":"Montay-Gruel","year":"2017","journal-title":"Radio. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105181_bib43","doi-asserted-by":"crossref","first-page":"927","DOI":"10.3390\/ijms15010927","article-title":"The effect of radiation on the immune response to cancers","volume":"15","author":"Park","year":"2014","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2026.105181_bib44","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1038\/s41375-021-01196-3","article-title":"Impact of bridging chemotherapy on clinical outcome of CD19 CAR T therapy in adult acute lymphoblastic leukemia","volume":"35","author":"Perica","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.critrevonc.2026.105181_bib45","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.phro.2022.05.008","article-title":"A phase 2 trial of deep-inspiration breath hold in radiotherapy of gastric lymphomas","volume":"22","author":"Petersen","year":"2022","journal-title":"Phys. Imaging Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105181_bib46","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1182\/bloodadvances.2020001837","article-title":"Bridging therapy prior to axicabtagene ciloleucel for relapsed\/refractory large B-cell lymphoma","volume":"4","author":"Pinnix","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.critrevonc.2026.105181_bib47","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1158\/0008-5472.CAN-08-3845","article-title":"Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and Lymphomas","volume":"69","author":"Ray-Coquard","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105181_bib48","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.ijrobp.2022.12.017","article-title":"Don\u2019t Put the CART Before the Horse: The Role of Radiation Therapy in Peri-CAR T-cell Therapy for Aggressive B-cell Non-Hodgkin Lymphoma","volume":"116","author":"Saifi","year":"2023","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2026.105181_bib49","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1001\/jamaoncol.2024.1113","article-title":"Comprehensive Bridging Radiotherapy for Limited Pre-CART Non-Hodgkin Lymphoma","volume":"10","author":"Saifi","year":"2024","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.critrevonc.2026.105181_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/frtra.2023.1238535","article-title":"Promises and challenges of a decentralized CAR T-cell manufacturing model","volume":"2","author":"Shah","year":"2023","journal-title":"Front Transpl."},{"key":"10.1016\/j.critrevonc.2026.105181_bib51","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/mp.16743","article-title":"Automatic dose prediction using deep learning and plan optimization with finite-element control for intensity modulated radiation therapy","volume":"51","author":"Shen","year":"2024","journal-title":"Med Phys."},{"key":"10.1016\/j.critrevonc.2026.105181_bib52","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ijrobp.2021.05.014","article-title":"Regulatory T Cells Shape the Differential Impact of Radiation Dose-Fractionation Schedules on Host Innate and Adaptive Antitumor Immune Defenses","volume":"111","author":"Sia","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2026.105181_bib53","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.ijrobp.2019.05.065","article-title":"Radiation Therapy as a Bridging Strategy for CAR T Cell Therapy With Axicabtagene Ciloleucel in Diffuse Large B-Cell Lymphoma","volume":"105","author":"Sim","year":"2019","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2026.105181_bib54","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aag1266","article-title":"The intersection of radiotherapy and immunotherapy: mechanisms and clinical implications","volume":"1","author":"Spiotto","year":"2016","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105181_bib55","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1748-717X-8-40","article-title":"Phase I trial of oral etoposide in combination with radiotherapy in head and neck squamous cell carcinoma - GORTEC 2004\u201302","volume":"8","author":"Tao","year":"2013","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105181_bib56","doi-asserted-by":"crossref","first-page":"5607","DOI":"10.1182\/bloodadvances.2020003001","article-title":"Predictive factors of early progression after CAR T-cell therapy in relapsed\/refractory diffuse large B-cell lymphoma","volume":"4","author":"Vercellino","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.critrevonc.2026.105181_bib57","doi-asserted-by":"crossref","unstructured":"Verginadis, I.I., Velalopoulou, A., Kim, M.M., Kim, K., Paraskevaidis, I., Bell, B., Oliaei Motlagh, S.A., Karaj, A., Banerjee, E., Finesso, G., Assenmacher, C.-A., Radaelli, E., Lu, J., Lin, Y., Putt, M.E., Diffenderfer, E.S., Guha, C., Qin, L., Metz, J.M., Maity, A., Cengel, K.A., Koumenis, C., Busch, T.M., 2024. FLASH proton reirradiation, with or without hypofractionation, mitigates chronic toxicity in the normal murine intestine, skin, and bone. https:\/\/doi.org\/10.1101\/2024.07.08.602528.","DOI":"10.1101\/2024.07.08.602528"},{"key":"10.1016\/j.critrevonc.2026.105181_bib58","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1186\/s12967-025-06567-3","article-title":"Efficacy and safety of a novel CD19, CD22 dual-targeted fully human loop bi-CAR-T for the treatment of relapsed\/refractory B cell non-Hodgkin lymphoma","volume":"23","author":"Wang","year":"2025","journal-title":"J. Transl. Med"},{"key":"10.1016\/j.critrevonc.2026.105181_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.166789","article-title":"Exploring low-dose radiotherapy to overcome radio-immunotherapy resistance","volume":"1869","author":"Wang","year":"2023","journal-title":"Biochim. Et. Biophys. Acta (BBA) Mol. Basis Dis."},{"key":"10.1016\/j.critrevonc.2026.105181_bib60","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0360-3016(00)01383-3","article-title":"Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large-cell immunoblastic lymphomas that have completely responded to CHOP-based induction chemotherapy","volume":"49","author":"Wilder","year":"2001","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2026.105181_bib61","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.ijrobp.2020.03.019","article-title":"Involved Site Radiation Therapy in Adult Lymphomas: An Overview of International Lymphoma Radiation Oncology Group Guidelines","volume":"107","author":"Wirth","year":"2020","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2026.105181_bib62","article-title":"Safety of Concurrent Radiation Therapy With Brentuximab Vedotin in the Treatment of Lymphoma","volume":"8","author":"Wu","year":"2023","journal-title":"Adv. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105181_bib63","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1182\/blood.2020006028","article-title":"ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemic","volume":"135","author":"Yahalom","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2026.105181_bib64","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004400","article-title":"PD-L1 blockade restores CAR T cell activity through IFN-\u03b3-regulation of CD163+ M2 macrophages","volume":"10","author":"Yamaguchi","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105181_bib65","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/j.ijrobp.2023.06.333","article-title":"Bridging Radiotherapy Prior to Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphomas: An ILROG Multi-Institutional Study","volume":"117","author":"Yegya-Raman","year":"2023","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826000685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826000685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T19:53:29Z","timestamp":1776974009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826000685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":65,"alternative-id":["S1040842826000685"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105181","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing bridging radiotherapy prior to CAR-T cell therapy: An evidence-based approach","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105181","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105181"}}